Andrew is a Chartered Chemist and a Fellow of The Royal Academy of Engineering as well as a Fellow of the Academy of Pharmaceutical Sciences. He is also a Visiting Professor of Biomaterials and Drug Delivery at the University of Brighton and has been recognized by the Pharmaceutical Society with an Excellence and Innovation Award.
Andrew has a wealth of experience in the technical and scientific field at several leading pharmaceutical and medical device companies. Most recently, he led a global, cross-functional team of technical leaders as Vice President of R&D with Innovation at Boston Scientific, where he drove multiple scientific collaborations with a number of highly regarded institutions, including Edinburgh University.
Jarl Severn, Managing Director at Owen Mumford, says Andrew’s experience and expertise will further help the company ensure innovation and scientific rigor are at the heart of its R&D strategies:
“Andrew is highly respected in the science and medical community, regularly speaking at conferences and contributing to scientific journals. He is recognized for developing R&D strategies and embracing the latest management approaches to fuel innovation pipelines targeting drug-device combinations. This innovative mindset will make him a tremendous asset to our company.”
Andrew is joining Owen Mumford at a pivotal time: “As a UK manufacturer, the company is rolling out several new devices designed to improve safety and convenience for healthcare professionals and patients,” he says. “I’m excited to support and advance Owen Mumford’s dedication to these vital safety priorities.”